XML 75 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Based Compensation - Omnibus Incentive Plan (Details) - Omnibus Plan - Stock Options - $ / shares
9 Months Ended 12 Months Ended
May 27, 2021
Sep. 30, 2021
Dec. 31, 2020
Stock based compensation      
Number of additional shares authorized 1,000,000    
Number of shares available for grant 2,200,000 970,832  
Stock options granted (in shares)   115,659  
Non-qualified stock options granted (in shares)   0 0
Number of shares      
Balance at beginning of year (in shares)   706,372  
Granted (in shares)   115,659  
Exercised (in shares)   (10,513)  
Forfeited (in shares)   (19,381)  
Balance at end of year (in shares)   792,137 706,372
Options: Options vested and exercisable   676,478  
Options: Options vested and expected to vest   792,137  
Weighted-Average Exercise Price      
Balance at beginning of year (in dollars per share)   $ 15.20  
Granted (in dollars per share)   29.62  
Exercised (in dollars per share)   5.25  
Forfeited (in dollars per share)   23.03  
Balance at end of year (in dollars per share)   17.35 $ 15.20
Weighted-Average Exercise Price: Options vested and exercisable   15.25  
Weighted-Average Exercise Price: Options vested and expected to vest   $ 17.35  
Weighted- Average Remaining Contractual Term (in Years)      
Balance (in years)   5 years 7 months 24 days 6 years 5 months 8 days
Granted (in years)   6 years 11 months 23 days  
Weighted-Average Remaining Contractual Term (in Years): Options vested and exercisable   5 years 5 months 1 day  
Weighted-Average Remaining Contractual Term (in Years): Options vested and expected to vest   5 years 7 months 24 days  
Number of unvested options scheduled to vest      
Non-Vested Options as of beginning of period   45,319  
Granted (in shares)   115,659  
Vested (in shares)   (45,319)  
Non-Vested Options as of end of period   115,659 45,319
Weighted-Average Grant Date Fair Value      
Non-Vested, beginning balance   $ 1.10  
Granted: Weighted-Average Grant Date Fair Value   17.43  
Vested: Weighted-Average Grant Date Fair Value   1.10  
Non-Vested, ending balance   $ 17.43 $ 1.10
Valuation Assumptions:      
Expected term in years   4 years 3 months 18 days  
Volatility (as a percent)   78.60%  
Risk-free interest rate   0.70%  
Granted: Weighted-Average Grant Date Fair Value   $ 17.43  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   7 years  
2021      
Number of unvested options scheduled to vest      
Non-Vested Options as of end of period   115,659